002755 Beijing Aosaikang Pharmaceutical
- 10.81
- -0.12-1.10%
Beijing Aosaikang Pharmaceutical News
Osecon: Half-year summary table of non-operating capital usage and other related capital transactions
Osecon: 2024 semi-annual financial report
Beijing Aosaikang Pharmaceutical: Announcement regarding the acceptance of the application for the listing permit of the subsidiary's Erlotinib tablets.
Beijing Aosaikang Pharmaceutical: Announcement regarding subsidiary's pharmaceutical registration certificate for injection of Fosaprepitant Dimeglumine.
Beijing Aosaikang Pharmaceutical: Legal Opinion on the 2023 Annual General Meeting of Shareholders of Beijing Aosaikang Pharmaceutical Co., Ltd.
Beijing Aosaikang Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Beijing Aosaikang Pharmaceutical: Announcement on the subsidiary obtaining a drug registration certificate for injectable isaconazole sulfate
Beijing Aosaikang Pharmaceutical: Report of the Audit Committee of the Board of Directors on the performance of supervisory duties by accountants in the 2023 annual review
Beijing Aosaikang Pharmaceutical: 2023 Annual Financial Report
Beijing Aosaikang Pharmaceutical: Board Audit Committee Annual Report Work Procedure (2024)
Beijing Aosaikang Pharmaceutical: Board Remuneration and Assessment Committee Rules of Procedure (2024)
Beijing Aosaikang Pharmaceutical: Notice on amending some clauses of the “Articles of Association”
Beijing Aosaikang Pharmaceutical: Independent Directors' Annual Report Work System (2024)
Beijing Aosaikang Pharmaceutical: 2023 Financial Results Report
Beijing Aosaikang Pharmaceutical: Internal Control Self-Assessment Report
Beijing Aosaikang Pharmaceutical: Board Audit Committee Rules of Procedure (2024)
Beijing Aosaikang Pharmaceutical: Special Meeting Work System for Independent Directors (2024)
Beijing Aosaikang Pharmaceutical: Board Nomination Committee Rules of Procedure (2024)
Beijing Aosaikang Pharmaceutical: Notice of Annual General Meeting of Shareholders
Beijing Aosaikang Pharmaceutical: Board Strategy Committee Rules of Procedure (2024)
Analysis
Price Target
No Data
No Data